XML 34 R21.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 30, 2018
Earnings Per Share [Abstract] |
Earnings Per Share | Footnote 15 — Earnings Per Share The computations of the weighted average shares outstanding for the periods indicated are as follows (in millions):
|  | Three months ended June 30, |  |  | Six months ended June 30, |
|  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
Weighted-average shares outstanding |  |  | 485.8 |  |  |  | 483.3 |  |  |  | 485.6 |  |  |  | 483.0 |
Share-based payment awards classified as participating securities (1) |  |  | 0.4 |  |  |  | 1.0 |  |  |  | 0.5 |  |  |  | 1.2 |
Basic weighted-average shares outstanding |  |  | 486.2 |  |  |  | 484.3 |  |  |  | 486.1 |  |  |  | 484.2 |
Dilutive securities (2) |  |  | — |  |  |  | 1.6 |  |  |  | — |  |  |  | 1.6 |
Diluted weighted-average shares outstanding |  |  | 486.2 |  |  |  | 485.9 |  |  |  | 486.1 |  |  |  | 485.8 |
(1) | For the three months ended June 30, 2018 and 2017 dividends and equivalents for share-based awards that are expected to be forfeited do not have a material effect on net income for basic and diluted earnings per share.
(2) | The three and six months ended June 30, 2018 excludes 0.8 million and 0.9 million potentially dilutive share-based awards as their effect would be anti-dilutive.
As of June 30, 2018, there were 1.7 million potentially dilutive restricted share awards with performance-based vesting targets that were not met and as such, have been excluded from the computation of diluted earnings per share. At June 30, 2018, there were approximately 2.5 million shares of the Company’s common stock that had not been issued to the former holders of Jarden shares who are exercising their right to judicial appraisal under Delaware law. Absent consent by the Company, these dissenting shareholders are no longer entitled to the merger consideration, but are instead entitled only to the judicially determined fair value of their shares, plus interest accruing from the date of the acquisition of Jarden, payable in cash (see Footnote 19).

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration